CD8A and neoplasm: CD8+ T cells, the major component of TILs, showed a significantly higher positivity rate in the high TIL group (78.9% vs 35.4%, P < 0.05), further supporting the central role of cytotoxic T cells in anti-tumor immunity (Figure 3b).